[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"sarcoma-retroperitoneal\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:sarcoma-retroperitoneal":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":47},"100553000","phase-3-high-versus-lower-intensity-surveillance-following-resection-of-retroperitoneal-sarcoma-100553000",false,"NCT06480396","High Versus Lower Intensity Surveillance Following Resection of Retroperitoneal Sarcoma","An International, Partially-randomised, Patient-preference Trial Within a Registry of High Versus Lower Intensity Radiological Surveillance Following Primary Resection of Retroperitoneal, Abdominal and Pelvic Soft Tissue Sarcoma","SARveillance","Inclusion Criteria:\n\n* Adult patients (greater than 18 years)\n* Primary resection\n* Histologically confirmed retroperitoneal, abdominal or pelvic soft tissue sarcoma\n* R0\u002FR1 resection\n* Eligible whether or not the participant undergoes neoadjuvant treatment\n\nExclusion Criteria:\n\n* Metastatic disease at time of randomisation\n* Recurrent, metastatic or residual disease identified on baseline CT imaging (3-4 months post primary resection)\n* Reoperation for recurrent soft tissue sarcoma\n* Re-resection following previous inadequate surgery\n* R2 resection\n* Patients receiving adjuvant therapy that will delay, interrupt or render radiological surveillance unpredictable\n* Uterine sarcomas, gastrointestinal stromal tumour (GIST), fibromatosis, epithelial tumours, multifocal disease, sarcomas of bony origin\n* Patient declined to consent to data sharing with RESAR (unless in a centre contributing via pre-planned IPDMA)","ALL","18 Years",{"count":20,"type":21},584,"ESTIMATED","INTERVENTIONAL",[24],"PHASE3","The SARveillance trial is an efficient, pragmatic, multi-centre, international, stratified, partially-randomised, patient-preference trial within a registry of high versus lower intensity radiological surveillance following primary resection of retroperitoneal, abdominal and pelvic soft tissue sarcoma. The trial design is stratified by sarcoma tumour grade (high\u002Fintermediate grade and low grade).",[27,28],"Sarcoma,Soft Tissue","Sarcoma Retroperitoneal",[30,31,32,33,34],"Surveillance","Radiology","Surgery","Quality of life","Cost-effectiveness","NOT_YET_RECRUITING","2024-10-14",{"date":38,"type":39},"2024-10-16","ACTUAL",{"date":41,"type":21},"2024-11",{"date":43,"type":21},"2033-12",{"name":45,"class":46},"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","OTHER",2]